Document 0397
 DOCN  M9440397
 TI    Oral empirical treatment of pneumonia. The challenge of choosing the
       best agent.
 DT    9404
 AU    Gleckman RA; Boston University School of Medicine.
 SO    Postgrad Med. 1994 Feb 1;95(2):165-72. Unique Identifier : AIDSLINE
       MED/94143248
 AB    Knowledge of the respiratory pathogens that cause pneumonia, combined
       with data obtained from the initial history, physical examination, and
       laboratory studies, provides the framework for an empirical approach to
       the treatment of community-acquired pneumonia. Selection of empirical
       therapy is based in large part on which of three broad groups the
       patient belongs to: previously well young adults, adults who are older
       or have a history of smoking or alcoholism, or HIV-infected adults.
       Several newer oral agents offer subtle advantages and disadvantages when
       compared with traditional agents, and these must be carefully weighed
       when prescribing treatment.
 DE    Administration, Oral  Anti-Infective Agents/*ADMINISTRATION & DOSAGE
       Human  Pneumonia/DIAGNOSIS/*DRUG THERAPY/MICROBIOLOGY  JOURNAL ARTICLE
       REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).